Dapagliflozin Impurity 71
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

898538-17-5Dapagliflozin Impurity 71

● In Stock

Catalogue No.:VE0028013
CAS No.:898538-17-5
Mol. Formula:C15H15BrO
Mol. Weight:291.18 g/mol

Additional information on CAS 898538-17-5

Parent drug

Dapagliflozin

IUPAC Name

1-bromo-3-(4-ethoxybenzyl)benzene

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

BrC1=CC=CC(CC2=CC=C(OCC)C=C2)=C1

InChI

InChI=1S/C15H15BrO/c1-2-17-15-8-6-12(7-9-15)10-13-4-3-5-14(16)11-13/h3-9,11H,2,10H2,1H3

Description

Dapagliflozin Impurity 71 (1-bromo-3-(4-ethoxybenzyl)benzene, CAS 898538-17-5) is a brominated aromatic byproduct encountered during key synthetic steps. The molecule (C15H15BrO, MW 291.19) is hydrophobic, shows a characteristic bromine isotope pattern in mass spectrometry, and typically elutes late on reversed-phase HPLC. Formation mechanisms include incomplete coupling or unintended bromination of benzyl intermediates; it is controlled by reaction stoichiometry and targeted purification. Analytical identification uses LC-MS for molecular ion and isotope confirmation, NMR for substitution pattern assignment, and orthogonal HPLC methods for quantification. Monitoring and setting limits for this impurity support regulatory impurity profiling and drug substance quality control.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url